CIK 0001062822
- Non-accelerated filer
- Smaller reporting company
LEXICON PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- LXRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 760474169
- Phone
- +1 281-863-3000
- Business address
- 2445 TECHNOLOGY FOREST BLVD., SUITE 1100, THE WOODLANDS, TX, 77381
- Former names
- LEXICON PHARMACEUTICALS, INC./DE, LEXICON GENETICS INC/TX
- 4 Open-market buy VP, Human Resources bought 6,000 shares at $1.84 ($11,040)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Chief Executive Officer bought 10,000 shares at $2.16 ($21,600)
- 4 Open-market buy VP, Human Resources bought 10,000 shares at $2.43 ($24,300)
- 4 Open-market buy Chief Executive Officer bought 20,000 shares at an average $2.34 ($46,742)
- 4 Open-market buy Chief Executive Officer bought 40,000 shares at $2.31 ($92,400)
- 4 Open-market buy President and CFO bought 12,000 shares at an average $2.33 ($28,000)
- 4 Open-market buy Director bought 27,775,050 shares at $2.60 ($72,215,130)
- 4 Exercise or conversion Director acquired 9,302 shares (option exercise)
- 4 Exercise or conversion Director acquired 9,302 shares (option exercise)
- 4 Exercise or conversion Director acquired 9,302 shares (option exercise)
- 4 Exercise or conversion Director acquired 9,302 shares (option exercise)
- 4 Exercise or conversion Director acquired 9,302 shares (option exercise)
- 4 Exercise or conversion Director acquired 9,302 shares (option exercise)
- 4 Exercise or conversion Director acquired 9,302 shares (option exercise)
- 4 Exercise or conversion Director acquired 9,302 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 7 of 34 · 673 filings